Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-1426

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition ; volume:7 ; number:1 ; day:13 ; month:8 ; year:2019 ; pages:1-21 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (13.8.2019), 1-21, 12.2019

Creator: Newton, Jared M.
Hanoteau, Aurelie
Liu, Hsuan-Chen
Gaspero, Angelina
Parikh, Falguni
Gartrell-Corrado, Robyn D.
Hart, Thomas D.
Laoui, Damya
Ginderachter, Jo A. Van
Dharmaraj, Neeraja
Spanos, William C.
Saenger, Yvonne
Young, Simon
Sikora, Andrew G.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40425-019-0698-6

URN: urn:nbn:de:101:1-2019123110364567381080

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Newton, Jared M.
Hanoteau, Aurelie
Liu, Hsuan-Chen
Gaspero, Angelina
Parikh, Falguni
Gartrell-Corrado, Robyn D.
Hart, Thomas D.
Laoui, Damya
Ginderachter, Jo A. Van
Dharmaraj, Neeraja
Spanos, William C.
Saenger, Yvonne
Young, Simon
Sikora, Andrew G.
SpringerLink (Online service)

Other Objects (12)

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Hochschulschrift

Immune checkpoint modulation enhances oncolytic virotherapy

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

Modulation of Tissue Microenvironment Following Myocardial Infarction

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity

Potential radiotherapy-related reactivation of immune checkpoint inhibitor hepatitis

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Dandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation

Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment

MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Hochschulschrift

Immune checkpoint modulation enhances oncolytic virotherapy

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

Modulation of Tissue Microenvironment Following Myocardial Infarction

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity

Potential radiotherapy-related reactivation of immune checkpoint inhibitor hepatitis

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Dandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation

Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment

MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Hochschulschrift

Immune checkpoint modulation enhances oncolytic virotherapy

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

Modulation of Tissue Microenvironment Following Myocardial Infarction

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity

Potential radiotherapy-related reactivation of immune checkpoint inhibitor hepatitis

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Dandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation

Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment

MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Immune checkpoint modulation enhances oncolytic virotherapy

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

Modulation of Tissue Microenvironment Following Myocardial Infarction

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity

Potential radiotherapy-related reactivation of immune checkpoint inhibitor hepatitis

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Dandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation

Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment

MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Immune checkpoint modulation enhances oncolytic virotherapy

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

Modulation of Tissue Microenvironment Following Myocardial Infarction

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity

Potential radiotherapy-related reactivation of immune checkpoint inhibitor hepatitis

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Dandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation

Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment

MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Immune checkpoint modulation enhances oncolytic virotherapy

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

Modulation of Tissue Microenvironment Following Myocardial Infarction

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment

Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity

Potential radiotherapy-related reactivation of immune checkpoint inhibitor hepatitis

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Dandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation

Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment

MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint

Related objects

Reset password